Traditionally, oral dutasteride has been prescribed for management of symptoms associated with benign prostatic hyperplasia, or BPH. The condition that affects men is also known as enlarged prostate, which compresses the bladder. BPH can cause urinary retention and an inability to empty the bladder completely. Dutasteride helps relieve these symptoms by preventing the conversion of testosterone into dihydrotestosterone, which causes prostate enlargement, ultimately reducing prostate gland size. New studies have shown that dutasteride is effective in treating male pattern baldness and may even be more effective than finasteride (brand name Propecia) and minoxidil (brand name Rogaine), two of the most popular medications that are currently recommended to treat patients with male pattern baldness. Dutasteride is currently pending FDA approval to treat male pattern baldness.
Despite producing promising results in clinical studies for treating hair loss, dutasteride has not yet been approved by the FDA as a hair loss treatment. Currently, the medications that are available on the market for managing male pattern baldness are limited to finasteride (Propecia) and minoxidil (Rogaine).






